Kathleen Morgan-Kehr

Kathleen Morgan-Kehr

Director/Sr. Prin. Sci.
Quantitative Systems Pharmacology

Kathleen Morgan-Kehr, Ph.D.
Director and Senior Principal Scientist
Quantitative Systems Pharmacology

About Kathleen
Dr. Morgan-Kehr’s work focuses on understanding the therapeutic modulation of the innate and adaptive immune system in a variety of inflammatory diseases. These processes are challenging to understand due to the complexity of positive and negative feedback loops and other immuno- modulatory mechanisms. This complex in silico work leverages known disease networks, including both immune and tissue cells, along with known cell-specific responses that are used to simulate clinical trials.

Prior to joining Simulations Plus, Dr. Morgan-Kehr worked at Immunetrics, Inc. for 14 years where she was involved with the development of several autoimmune QSP models for Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, Ulcerative Colitis, Crohn’s Disease, Systemic Lupus Erythematosus as well as early development of immune-oncology models.

Dr. Morgan-Kehr received her Ph.D. in Biochemistry and Molecular Genetics from the University of Pittsburgh School of Medicine in Pittsburgh, PA, and a Bachelor of Science from Westminster College, in New Wilmington, PA.

Latest Simulations Plus Research